Takeda aims for dengue vaccine inclusion in India's shots program

Health CareJab recently approved for disease that infected 120,000 people last yearTakeda Pharmaceutical's Qdenga is the first vaccine to ever be approved for dengue prevention by India's Central Drugs Standard Control Organisation. © ReutersSOUMYAJIT SAHAAugust 5, 2026 10:41 JSTMUMBAI -- Japanese drugmaker Takeda Pharmaceutical is aiming to have its dengue vaccine become a part of India's national immunization program, a senior company executive said, after the country's regulators approved the product last month.